内源性库欣综合征对全因及特定原因死亡率的影响
系统综述与Meta分析评估良性内源性库欣综合征患者的全因和特定原因死亡率。14篇文章报告标准化死亡比(SMR),总体SMR为3.0(95%CI 2.3-3.9;I²=80.5%),库欣病为2.8,肾上腺库欣为3.3。87篇文章报告死亡比例,2000年前后死亡比例从10%降至3%。死因主要为动脉粥样硬化性疾病和血栓栓塞(43.4%)。
要点
- 库欣综合征总体SMR为3.0(95%CI 2.3-3.9;I²=80.5%),库欣病SMR为2.8,肾上腺库欣SMR为3.3(95%CI 0.5-6.6,未达统计学显著)。
- 2000年前发表文章的死亡比例为10%,2000年至最后检索期间为3%,差异有统计学意义。
- 主要死因为动脉粥样硬化性疾病和血栓栓塞(43.4%),其次为感染(12.7%)和恶性肿瘤(10.6%)。
核心结论
- 尽管近年来结局有所改善,库欣综合征患者的死亡率仍持续升高,死亡原因提示除治疗高皮质醇血症外还需预防和管理合并症。
研究设计与样本
- 系统综述与Meta分析,方案注册于PROSPERO(CRD42017067530),检索PubMed、EMBASE、CINHAL、Web of Science和Cochrane Central从建库至2021年1月。
主要发现
- 14篇文章报告SMR,共3691例患者(13个库欣病队列和7个肾上腺库欣队列),总体SMR为3.0(95%CI 2.3-3.9;I²=80.5%),库欣病为2.8(95%CI 2.1-3.7;I²=81.2%),肾上腺库欣为3.3(95%CI 0.5-6.6;I²=77.9%)。
- 87篇文章报告死亡比例,共19181例库欣综合征患者(53个库欣病、24个肾上腺库欣和20个混合库欣队列),所有亚型总体死亡比例为0.05(95%CI 0.03-0.06),Meta回归分析显示亚型间无差异(P=.052)。
- 2000年前发表文章的死亡比例为0.1(10%),2000年至最后检索期间为0.03(3%),库欣综合征(P<.001)、库欣病(P<.001)和肾上腺库欣(P=.01)均显示差异。
- 死因为动脉粥样硬化性疾病和血栓栓塞(43.4%)、感染(12.7%)、恶性肿瘤(10.6%)、活动性疾病(3.5%)、肾上腺功能不全(3.0%)和自杀(2.2%)。
关键数值与推荐
- 总体库欣综合征SMR为3.0(95%CI 2.3-3.9;I²=80.5%)。
- 库欣病SMR为2.8(95%CI 2.1-3.7;I²=81.2%)。
- 肾上腺库欣SMR为3.3(95%CI 0.5-6.6;I²=77.9%),置信区间跨1,未达统计学显著。
- 2000年前死亡比例为0.1(10%),2000年至最后检索期间为0.03(3%),P<.001(库欣综合征和库欣病)及P=.01(肾上腺库欣)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to perform a systematic review and meta-analysis of all-cause and cause-specific mortality of patients with benign endogenous Cushing syndrome (CS). METHODS: The protocol was registered in PROSPERO (CRD42017067530). PubMed, EMBASE, CINHAL, Web of Science, and Cochrane Central searches were undertaken from inception to January 2021. Outcomes were the standardized mortality ratio (SMR), proportion, and cause of deaths. The I2 test, subgroup analysis, and meta-regression were used to assess heterogeneity across studies. RESULTS: SMR was reported in 14 articles including 3691 patients (13 Cushing disease [CD] and 7 adrenal CS [ACS] cohorts). Overall SMR was 3.0 (95% CI, 2.3-3.9; I2 = 80.5%) for all CS, 2.8 (95% CI, 2.1-3.7; I2 = 81.2%) for CD and 3.3 (95% CI, 0.5-6.6; I2 = 77.9%) for ACS. Proportion of deaths, reported in 87 articles including 19 181 CS patients (53 CD, 24 ACS, and 20 combined CS cohorts), was 0.05 (95% CI, 0.03-0.06) for all CS subtypes with meta-regression analysis revealing no differences between CS subtypes (P = .052). The proportion of deaths was 0.1 (10%) in articles published before 2000 and 0.03 (3%) in 2000 until the last search for CS (P < .001), CD (P < .001), and ACS (P = .01). The causes of death were atherosclerotic diseases and thromboembolism (43.4%), infection (12.7%), malignancy (10.6%), active disease (3.5%), adrenal insufficiency (3.0%), and suicide (2.2%). Despite improved outcomes in recent years, increased mortality from CS persists. The causes of death highlight the need to prevent and manage comorbidities in addition to treating hypercortisolism.
引用
- Limumpornpetch P, Morgan AW, Tiganescu A, et al. The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality. J Clin Endocrinol Metab. 2022. PMID: 35486378. doi:10.1210/clinem/dgac265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。